Trial Profile

A multinational, prospective, two-arm, observational study to collect real-world data on joint and bone health in patients receiving prophylaxis with simoctocog alfa or emicizumab in routine clinical practice

Status: Planning

Phase of Trial: Phase IV

Latest Information Update: 25 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

25 Jan 2024 New trial record
09 Dec 2023 According to the trial design presented at 65th American Society of Hematology Annual Meeting and Exposition, an interim analysis is planned after 2 years.
09 Dec 2023 Trial design presented at 65th American Society of Hematology Annual Meeting and Exposition.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com